Insmed Inc (NAS:INSM)
$ 69.61 -1.06 (-1.5%) Market Cap: 12.45 Bil Enterprise Value: 12.18 Bil PE Ratio: 0 PB Ratio: 25.75 GF Score: 67/100

Insmed Inc Investor and Analyst Event Transcript

May 08, 2023 / 12:00PM GMT
Release Date Price: $18.9 (-2.58%)
Bryan Dunn

Good morning, everyone, and welcome to The Future of Rare at Insmed: Functional Genes, AI-Enhanced Proteins, Glowing Algae, and More.

For those who may not yet know me, my name is Bryan Dunn, and I have the privilege of leading Investor Relations here at Insmed. And given that the word "Future" is in the name of this event, it will come as no surprise to any of you that we will be making forward-looking statements during today's presentation.

So before we begin, on the slide behind me, you will find additional information about risks and uncertainties associated with those statements.

With that, we will begin the presentation with this short video.

(presentation)

William H. Lewis
Insmed Incorporated - President, CEO & Chairman

"Count us in". The idea of "Count us in" comes from a story about a young man who visited Insmed almost 10 years ago with his mom. The whole company numbered about 30 employees at that time, and our inhaled antibiotic was being considered for treating patients with cystic fibrosis. This

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot